Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Progressive Supranuclear Palsy Clinical Trial Platform

NCT07173803 is registered in ClinicalTrials.gov with Adam Boxer as lead sponsor.

NCT NCT07173803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07173803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Progressive Supranuclear Palsy Clinical Trial Platform
Lead sponsor
Adam Boxer
Phase
Phase 2
Overall status
Recruiting
Start date
July 29, 2026
Completion date
September 28, 2030
Enrollment
440 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

progressive supranuclear palsy(psp)